[HLFG] QoQ Annualized Quarter Result on 31-Dec-2011 [#2]

Announcement Date
27-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2012
Quarter
31-Dec-2011 [#2]
Profit Trend
QoQ- 4.67%
YoY- -58.22%
View:
Show?
Annualized Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 4,321,516 4,158,163 4,160,464 3,961,384 3,581,388 3,665,505 3,616,420 12.57%
PBT 2,754,852 2,393,748 2,443,608 1,950,286 1,962,492 2,422,684 2,542,080 5.48%
Tax -681,908 -540,310 -549,586 -451,584 -493,444 -350,817 -321,322 64.91%
NP 2,072,944 1,853,438 1,894,021 1,498,702 1,469,048 2,071,867 2,220,757 -4.47%
-
NP to SH 1,388,788 1,233,568 1,303,950 929,394 887,928 1,673,579 1,835,800 -16.93%
-
Tax Rate 24.75% 22.57% 22.49% 23.15% 25.14% 14.48% 12.64% -
Total Cost 2,248,572 2,304,725 2,266,442 2,462,682 2,112,340 1,593,638 1,395,662 37.31%
-
Net Worth 9,158,100 8,897,207 7,255,878 7,258,238 7,265,078 7,467,605 7,298,340 16.28%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 540,546 259,848 345,518 207,378 415,147 290,406 386,484 24.98%
Div Payout % 38.92% 21.06% 26.50% 22.31% 46.75% 17.35% 21.05% -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 9,158,100 8,897,207 7,255,878 7,258,238 7,265,078 7,467,605 7,298,340 16.28%
NOSH 1,039,511 1,039,393 1,036,554 1,036,891 1,037,868 1,037,167 1,035,225 0.27%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 47.97% 44.57% 45.52% 37.83% 41.02% 56.52% 61.41% -
ROE 15.16% 13.86% 17.97% 12.80% 12.22% 22.41% 25.15% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 415.73 400.06 401.37 382.04 345.07 353.41 349.34 12.26%
EPS 133.60 118.60 125.73 89.60 85.60 161.40 177.33 -17.15%
DPS 52.00 25.00 33.33 20.00 40.00 28.00 37.33 24.65%
NAPS 8.81 8.56 7.00 7.00 7.00 7.20 7.05 15.97%
Adjusted Per Share Value based on latest NOSH - 1,035,840
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 380.83 366.43 366.64 349.09 315.61 323.02 318.69 12.57%
EPS 122.39 108.71 114.91 81.90 78.25 147.48 161.78 -16.93%
DPS 47.63 22.90 30.45 18.27 36.58 25.59 34.06 24.97%
NAPS 8.0705 7.8405 6.3941 6.3962 6.4023 6.5807 6.4316 16.28%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 11.86 12.24 12.30 11.66 10.90 13.18 9.00 -
P/RPS 2.85 3.06 3.06 3.05 3.16 3.73 2.58 6.84%
P/EPS 8.88 10.31 9.78 13.01 12.74 8.17 5.08 44.96%
EY 11.26 9.70 10.23 7.69 7.85 12.24 19.70 -31.05%
DY 4.38 2.04 2.71 1.72 3.67 2.12 4.15 3.65%
P/NAPS 1.35 1.43 1.76 1.67 1.56 1.83 1.28 3.60%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 14/11/12 28/08/12 16/05/12 27/02/12 30/11/11 26/08/11 10/05/11 -
Price 12.70 12.18 11.72 11.76 11.40 11.68 11.14 -
P/RPS 3.05 3.04 2.92 3.08 3.30 3.30 3.19 -2.93%
P/EPS 9.51 10.26 9.32 13.12 13.33 7.24 6.28 31.77%
EY 10.52 9.74 10.73 7.62 7.50 13.82 15.92 -24.07%
DY 4.09 2.05 2.84 1.70 3.51 2.40 3.35 14.18%
P/NAPS 1.44 1.42 1.67 1.68 1.63 1.62 1.58 -5.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment